loadpatents
name:-0.019170999526978
name:-0.012710094451904
name:-0.0013070106506348
Litwin; Virginia M. Patent Filings

Litwin; Virginia M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Litwin; Virginia M..The latest application filed is for "method for preventing hiv-1 infection of cd4+ cells".

Company Profile
0.10.16
  • Litwin; Virginia M. - Amwell NJ US
  • Litwin; Virginia M. - Fayetteville NY
  • Litwin; Virginia M. - West Amwell NJ
  • Litwin; Virginia M. - Eayetteville NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For Preventing Hiv-1 Infection Of Cd4+ Cells
App 20130211043 - Allaway; Graham P. ;   et al.
2013-08-15
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion
Grant 7,935,797 - Allaway , et al. May 3, 2
2011-05-03
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
Grant 7,901,685 - Allaway , et al. March 8, 2
2011-03-08
Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion
Grant 7,862,994 - Allaway , et al. January 4, 2
2011-01-04
Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists
Grant 7,858,298 - Allaway , et al. December 28, 2
2010-12-28
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
App 20090155774 - Allaway; Graham P. ;   et al.
2009-06-18
Compounds Capable Of Inhibiting Hiv-1 Infection
App 20080226651 - Litwin; Virginia M. ;   et al.
2008-09-18
Method for preventing HIV-1 infection of CD4 cells
App 20080187539 - Allaway; Graham P. ;   et al.
2008-08-07
Method for preventing HIV-1 infection of CD4+ Cells
App 20080138897 - Allaway; Graham P. ;   et al.
2008-06-12
Compounds capable of inhibiting HIV-1 infection
Grant 7,345,153 - Litwin , et al. March 18, 2
2008-03-18
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
App 20070048820 - Allaway; Graham P. ;   et al.
2007-03-01
Compounds capable of inhibiting HIV-1 infection
App 20070025983 - Litwin; Virginia M. ;   et al.
2007-02-01
Methods for inhibiting HIV-1 infection
Grant 7,118,859 - Litwin , et al. October 10, 2
2006-10-10
Uses of a chemokine receptor for inhibiting HIV-1 infection
App 20060194244 - Allaway; Graham P. ;   et al.
2006-08-31
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
App 20060140977 - Allaway; Graham P. ;   et al.
2006-06-29
Method for preventing HIV-1 infection of CD4+ cells
App 20060029932 - Allaway; Graham P. ;   et al.
2006-02-09
Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same
Grant 6,972,126 - Allaway , et al. December 6, 2
2005-12-06
Uses of a chemokine receptor for inhibiting HIV-1 infection
App 20040086528 - Allaway, Graham P. ;   et al.
2004-05-06
Methods For Using Resonance Energy Transfer- Based Assay Of Hiv-1 Envelope Gylcoprotein-mediated Membrane Fusion, And Kits For Practicing Same
App 20030044770 - ALLAWAY, GRAHAM P. ;   et al.
2003-03-06
Method for preventing HIV-1 infection of CD4+ cells
App 20020155429 - Allaway, Graham P. ;   et al.
2002-10-24
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
App 20020045161 - Allaway, Graham P. ;   et al.
2002-04-18
Method for preventing HIV-1 infection of CD4+ cells
Grant 6,344,545 - Allaway , et al. February 5, 2
2002-02-05
Compounds capable of inhibiting HIV-1 infection
App 20010046512 - Litwin, Virginia M. ;   et al.
2001-11-29
Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion
Grant 6,261,763 - Allaway , et al. July 17, 2
2001-07-17
Method for preventing HIV-1 infection of CD4.sup.+ cells
Grant 6,107,019 - Allaway , et al. August 22, 2
2000-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed